弁護士・外国弁護士等
取扱分野
産業
分野
エネルギーおよび天然資源
スポーツ、メディアおよびエンターテインメント
テクノロジー&テレコム
ライフサイエンス&ヘルスケア
運輸&ロジスティックス
教育
金融機関
航空宇宙および防衛
自動車
消費財
不動産
保険
企業と財務
政府規制
訴訟、仲裁および雇用
知的財産
ケーススタディ
論文・書籍等
All Our thinking
Comparative guides
Digital Client Solutions
セミナー等のご案内
Podcasts
News
Hogan Lovells 2024 Election Impact and Congressional Outlook Report
ESG
採用情報
検索
検索
日本語
Deutsch
English
Español
Français
日本語
中文
False
Mobile area
ホーガン・ロヴェルズについて
概要
拠点
ニュース
広報担当
プレスリリース
受賞・ランキング
社会貢献
アルムナイ・ネットワーク
論文・書籍等
最新の法律、市場、規制の動向を先取りする.
論文・書籍等に戻る
Search
Topics
Global Market Issues
Administrative and Public Law
Aerospace and Defense
Antitrust and Competition
Automotive and Mobility
Banking and Loan Finance
Business and Human Rights
Capital Markets
Construction and Engineering
Consumer
Corporate Governance / Public Company Advisory / Company Law
Education
Employment
Energy and Natural Resources
Environment
Esports and Gaming
Executive Compensation, Employee Benefits and Share Incentives
Financial Services
Food and Beverage
Gaming and Gambling Law
Government Contracts and Public Procurement
Government Relations
Health Regulatory
Infrastructure, Energy, Resources and Projects
Insurance / re-insurance
Intellectual Property
International Arbitration
International Trade and Investment
Investigations, White Collar and Fraud
Life Sciences and Health Care
Manufacturing and Industrials
Media and Entertainment
Medical Device and Technology Regulatory
Mergers and Acquisitions
Pensions
Pharmaceuticals and Biotechnology Regulatory
Privacy and Cybersecurity
Private Capital
Private Equity, Venture Capital and Investment Funds
Products Law
Real Estate
REITs
Restructuring and Special Situations
Risks, Disputes and Litigation
Space and Satellite
Sports
Strategic Operations, Agreements and Regulation
Sustainable Finance
Tax
Technology
Telecommunications and Internet
Transfer Pricing
Transportation and Logistics
Artificial Intelligence
Brexit
COVID-19
Digital Transformation
Digital Services Act and Digital Markets Act
ESG, Sustainability, and Climate
EU Green Deal
Federal Trade Commission (FTC)
Foreign Direct Investment
Inflation Reduction Act
Russia sanctions
Supply Chain
UK2030
Commercial Human Rights
Constitutional Law
Freedom of Information
Judicial Review
Public Law
Competition Litigation and Disputes
Leveraged and Acquisition Finance
Derivatives and Structured Products
Equity Capital Markets
General Debt Capital Markets
High Yield
Securitization and Structured Finance
Trust and Agency
E-Commerce
Electronics and Consumer Appliances
Retail and Fashion
Energy Transition
Hydrogen
Mining
Nuclear
Oil, Gas and LNG
Power, renewables and alternative energy
Environmental Compliance, Litigation and Internal Investigations
Banking Products
Consumer Finance
Digital Assets and Blockchain
Financial Crime including Anti-money Laundering
Financial Services Litigation and Disputes
Financial Services Privacy
Financial Services Regulatory Investigations and Enforcement
Financial Services Securities and Markets Regulation
FinTech
Funds and Asset Management
Open Banking
Payments
Prudential Regulation
Gaming and Gambling Related Payments Services
Online Gaming and Gambling
Congressional Oversight and Investigation
Devolution and devolved administrations
Federal Funding and Appropriations
Legislation and Policy Engagement and Development
Political Law Compliance
Public Policy and Regulation
Sovereign Government Relations and Public Affairs
State,Local Government Representation and Policy
UK Parliamentary Affairs
Coverage and Reimbursement
Drug Pricing and Government Reporting
Health Compliance, Fraud and Abuse
Health Insurance Plans and Managed Care
Health Policy and Advocacy
Health Privacy
Copyright
Designs
Domain Names
IP and Technology Transactions
Patents
Trademarks and Brands
Trade Secrets and Confidential Know-how
Unfair Competition
Bribery and Corruption
False Claims Act
Financial Crime
Investigations, Regulatory and Compliance
Whistleblowing
Cell, Tissue, and Gene Therapies (CTGT)
Clinical Trials
Combination Products
Digital Health
Emerging Companies and Investors
Hospitals and Health Care Providers
Licensing and Commercial Transactions
Life Science Government Enforcement and Compliance
Chemicals and Industrial Products and Services
Conglomerates
Advertising and Promotion of Medical Devices
Clinical Studies Product Design and Development
Conformity Assessment Procedure,CE Mark
In Vitro Diagnostics
Joint Ventures and Strategic Alliances
MDR,IVDR
Medical Device Software and Cybersecurity
Postmarket Performance
Premarket Strategy, Submissions, and Review
Regulatory Inspections and QSR-ISO 13485
State Licensing of Medical Device
Joint Ventures and Strategic Alliances
Advertising and Promotion of Pharmaceuticals and Biotechnology
Biologics and Biosimilars
Controlled Substances
Life Cycle Management of Pharmaceuticals and Biotechnology
OTC Drugs and Cosmetics
Regulatory Exclusivities, Hatch-Waxman, and Similar Statutes
Regulatory Inspections and cGMP
Fund Formation, Fund Raising, Restructuring and Dissolution
Infrastructure and Energy Funds
Investments, Financing, Portfolio Company Advice and Exits
Pension Funds
Private Capital Regulatory, Compliance and Disputes
Private Credit-Debt Funds
Private Equity Funds
Real Estate Investment Vehicles and Funds
Sovereign Wealth Funds
Venture Capital Funds
Fund Formation, Fund Raising, Restructuring and Dissolution
Management Incentive Programs
Private Equity Transactions
Secondaries
Venture Capital Transactions
Cross-border Real Estate
Development, Planning and Land Use
ESG in Real Estate
Hotels and Leisure
Real Estate Investment Vehicles and Funds
Real Estate Disputes
Real Estate Finance
Business Restructuring and Insolvency Litigation
Class Actions and Group Actions
Competition Litigation and Disputes
Corporate and Securities Litigation
Crisis Management
Financial Services Litigation and Disputes
Global Asset Recovery and Enforcement
Real Estate Disputes
Sovereign Asset Recovery
Technology Litigation and Disputes
U.S. Appellate and Supreme Court Litigation
Commercial Law and Contracts
Logistics
Mobility
Rail
Shipping
Uncrewed Aircraft Systems-Advanced Air Mobility-Drone Security
Countries
Australia
Belgium
Brazil
France
Germany
Hong Kong
Hungary
Indonesia
Ireland
Italy
Japan
Luxembourg
Mexico
Mongolia
Netherlands
People's Republic of China
Poland
Saudi Arabia
Singapore
South Africa
South Korea
Spain
United Arab Emirates
United Kingdom
United States
Vietnam
Language
English
中文
Deutsch
Español
Français
日本語
Português
Date
Within 30 days
Within 3 months
Within 1 year
Within 2 years
All publications
Search
Clear
"{0}"
ニュース
EU医薬品規制改正案と知的財産
一般社団法人日本知的財産協会「知財管理」
2024年8月号
ニュース
英国の選挙:英国市場において製品やサービスを提供する企業にとってすべての「変化」となるか?
02 7月 2024
ニュース
$name
10 10月 2023
ニュース
$name
10 10月 2023
ニュース
ロンドンを仲裁地とする事案に関する最近の英国最高裁判所 の事件の概要と組織内弁護士への示唆
JCAジャーナル
2021年5月
ニュース
Doing business in the United States 2021 | 米国でビジネスをするということ
2021年5月20日
ニュース
将来のための取引?
2021年4月12日
[SEC Update] 2016 Proxy Season: SEC Staff Issues Important Guidance on Key Shareholder Proposal Exclusions
SEC Update
11 12月 2015
[Newsletter] Upcoming D.C. Program Explores Where We Are Headed with Section 5 of the FTC Act
Hogan Lovells Chronicle of Data Protection
October 2015
ニュース
[Energy Alert] Back to the Future — Advanced Reactor Prototype
Energy Alert
29 9月 2015
A guide to the new regime for competition claims in the UK
September 2015
[Health Alert] 340B Program: HRSA Releases Proposed “Omnibus” or “Mega” Guidance, Which Lives Up To Its Name
Health, Pharmaceutical, and Biotechnology Alert
28 8月 2015
No results found
load-more-search
Digital Client Solutions
Empowering you to lead change through our digital solutions.
Learn more